French guidelines on the use of systemic treatments for moderate-to-severe psoriasis in adults
The European academy of dermatology and venereology published new guidelines - French guidelines on the use of systemic treatments for moderate-to-severe psoriasis in adults:
F. Amatore,1,†A.-P. Villani,2,†M. Tauber,3,†M. Viguier,4,5,* B. Guillot,5,6on behalf of the PsoriasisResearch Group of the French Society of Dermatology (Groupe de Recherche sur le Psoriasis de la SocieteFrancßaise de Dermatologie)
1Dermatology Department, Timone Hospital, Aix-Marseille University, Marseille, France
2Dermatology Department, Edouard Herriot Hospital, Lyon University, Lyon, France
3Dermatology and Allergology Department, Larrey Hospital, Toulouse University, Toulouse, France
4Dermatology Department, Robert Debre Hospital, Reims University, Reims, France
5Centre de Preuves en Dermatologie, Paris, France
6Dermatology Department, CHU of Montpellier, Montpellier University, Montpellier, France*Correspondence:M. Viguier.E-mail:firstname.lastname@example.org
These guidelines were developed by the psoriasis research group of the French Society of Dermatology with the aim of pro-viding updated decision-making algorithms for the systemic treatment of adult patients with moderate-to-severe psoriasis.Our algorithms were generated after rigorous evaluation of existing guidelines on the treatment of psoriasis and of publica-tions concerning new systemic treatments, not yet incorporated into existing guidelines.
A total of nine existing guidelines and 53 publications related to new systemic treatments were found to meet our criteria for use in the generation of the algo-rithms. We have proposed two new algorithms to assess therapeutic responses, both of which incorporate emerging criteriafor evaluating treatment goals.
Updated therapeutic strategy algorithms, incorporating both established and new systemictherapies, were also generated for the treatment of plaque psoriasis and psoriatic arthritis, together with recommendationsfor the treatment of particular forms of psoriasis and treatment of patients with comorbidities.
Read the whole paper in the PDF file BELOW
7 April 2018;